IT STARTED OUT IN LONG TERM CARE, BUT THEY FOUND THAT IT REALLY IS USED AND PROMOTES SOME JOY, HAPPINESS, DECREASED ANXIETY. SO ONE OF THE THINGS THAT PATIENTS LIVING WITH DEMENTIA. 75% OF THEM ...
Results from an exploratory phase 2 clinical trial of a small molecule oligomer antagonist found treatment improved outcomes in patients with dementia ... reduction in anxiety symptoms ...